Related by context. All words. (Click for frequent words.) 77 abstr 76 Oral Presentation 76 Abstract # 75 Nephrol 75 Suppl. 74 Poster Discussion 74 Antiviral Therapy 73 FASEB J. 73 Suppl 72 Obstet Gynecol 72 J Am Soc 72 J Clin Oncol 72 Cancer Res 72 Poster Presentation 72 Proc Am Soc 72 Neurol 71 J Clin 71 Arch Neurol 71 Late Breaker 71 Oral Fingolimod 71 J Natl Cancer Inst 70 Am J Epidemiol 70 #:#-# [020] 70 Ann Rheum Dis 70 Nat Genet 70 Vitro Activity 70 Nat Clin Pract 70 Abstract Full Text 70 Br J Psychiatry 70 Curr Opin 70 #:#-# [031] 70 Clin Oncol 70 Neurosurg 70 J Pediatr 70 Ann Intern Med 70 doi #.#/fj.#-# 70 Antigen Specific 70 Eur J Cancer 70 Kinase Inhibitor 69 Dermatol 69 J Biol Chem 69 suppl. 69 Oncol 69 J Clin Endocrinol Metab 69 Am J Cardiol 69 Ann Oncol 69 Relapsing Multiple Sclerosis 69 Nucleic Acids Res 69 Pediatr 69 Arch Intern Med 69 Eur Respir J 69 Anesth 69 Arch Dermatol 69 J Nutr 69 Crit Care Med 69 Eur J 69 suppl 69 Novel Inhibitor 69 Thromb Haemost 69 Kidney Int 69 S# S# [001] 69 Rheumatol 69 Immunol 68 J Child Adolesc 68 Selective Cardiac Myosin 68 Cardiol 68 #:#-# [023] 68 J Clin Psychiatry 68 Nat Med 68 Psychiatry Clin Neurosci 68 Safety Tolerability 68 Proc Natl Acad Sci 68 Int J Radiat Oncol 68 EMBO J. 68 Dendritic Cells 68 Environ Health Perspect 68 Proc Am 68 Crit Care 68 Oral Session 68 Preclinical Data 68 Br J Cancer 68 #S #S [002] 68 Orthop Surg 68 Abstract Free Full Text 68 Free Full Text 68 Clinical Trial Results 67 Biol Psychiatry 67 Anti Tumor Activity 67 Ophthalmol 67 Mol Cell 67 Castration Resistant Prostate Cancer 67 Preclinical Study 67 Int J Epidemiol 67 J Rheumatol 67 Am J Physiol 67 Antiviral Activity 67 Supplemental Figure 67 Obes Res 67 #:#-# [025] 67 Arch Gen Psychiatry 67 Eur Arch 67 Schizophr Bull 67 Nephrol Dial Transplant 67 Pharmacokinetics PK 67 #S #S [003] 67 Pharmacokinetic Study 67 Pathol 67 Toxicol 67 Am J Clin 67 Poster Session 67 Dose Ranging Study 67 Phase Ib Clinical Trial 67 DOI #.#/S#-# 67 Cochrane Database Syst Rev. 67 J Am Coll 67 Am J Pathol 67 Prolongs Survival 67 J Nerv Ment Dis 67 Hepatocellular 67 J Allergy Clin 67 J Am Acad 67 Crit Rev 67 Hematol 67 Psychopharmacol 67 J Clin Invest 67 Eur J Endocrinol 67 #:#-# [033] 67 Br J Dermatol 67 Biol 66 #-# Full Text 66 Nat Rev 66 Nutr 66 Endocrinol 66 Endocrinol Metab 66 Int J 66 Child Adolesc Psychiatry 66 Lancet Oncol 66 J Affect Disord 66 I# I# [002] 66 Eur Urol 66 Int J Cancer 66 II Clinical Trial 66 Infect Dis 66 HCV Genotype 66 Gynecol Oncol 66 J Virol 66 Adjuvant Chemotherapy 66 Systemic Sclerosis 66 Gastrointestinal Cancers Symposium 66 xenograft model 66 Soc Sci Med 66 Cell Physiol 66 vesicular monoamine transporter 66 ANN INTERN MED 66 Neurosci 66 Arch Pediatr Adolesc Med 66 Study Evaluating 66 N Engl J 66 Diagn 66 Antitumor Activity 66 Psychiatry Res 66 Clinical Outcome 66 Polymorphism 66 Am J Gastroenterol 65 Mouse Model 65 CD# [004] 65 MET VEGFR2 65 patrick.graham @ thomson.com 65 Multiple Myeloma MM 65 J Appl 65 J Med 65 Psychol Med 65 J Urol 65 Plus Ribavirin 65 Clin Infect Dis 65 PMID # [002] 65 Ptf 65 IN PATIENTS WITH 65 Int Clin Psychopharmacol 65 Br J 65 Clin Chem 65 Randomized Phase 65 Phase 2b Study 65 deoxy 65 Pooled Analysis 65 doi #.#/S#-# 65 Clin Pharmacol Ther 65 Psychopharmacol Bull 65 Cell Biol 65 Novel Oral 65 Antitumor activity 65 J Psychiatry 65 Am J Respir 65 Activator CK # 65 Acta Psychiatr Scand 65 J Clin Psychopharmacol 65 Rehabil 65 Prostatic 65 Phase 2b Clinical Trial 65 Progenitor Cells 65 Hsp# Inhibitor 65 Hormone Refractory Prostate Cancer 65 Anti Tumor 65 #:#-# [029] 65 Chronic Hepatitis C 65 transthyretin TTR mediated amyloidosis 65 Sipuleucel T 65 Chronic Lymphocytic Leukemia 65 Treated Patients 65 Bortezomib 65 PEG IFN 65 Microbiol 65 Med Assoc 65 Immune Responses 65 Heart Circ Physiol 65 Parathyroid Hormone 65 Ann Emerg Med 65 Urol 65 Eur Heart 65 Alkaline Phosphatase 65 Decitabine 65 ASCO Abstract 65 Cancer J Clin 65 Psychol 65 Dent Res 65 Dose Escalation 64 Pract 64 Soft Tissue Sarcoma 64 #:#-# [035] 64 suppl #S 64 Phospholipase A2 64 Mol Biol 64 Physiol 64 Prognostic significance 64 Tyrosine Kinase Inhibitor 64 Anticancer Drugs 64 J Clin Epidemiol 64 Kidney Transplant Recipients 64 Biol Phys 64 Adefovir 64 Phys Ther 64 Polymerase Inhibitor 64 Double Blind Randomized 64 Drug Candidate 64 UNI XC 64 Tumor Progression 64 Protein Kinase 64 polycythemia vera PV 64 Peripheral Arterial 64 Proteasome 64 J Foot Ankle 64 Meets Primary Endpoint 64 Preclinical Evaluation 64 S1 S# [002] 64 Sports Exerc 64 Cytochrome P# 64 Plaque Psoriasis 64 histone deacetylase HDAC inhibitor 64 #:# -# [004] 64 Androgen Receptor 64 Fast Skeletal Troponin 64 Initiated Phase 64 Severe Sepsis 64 Orally Active 64 Mg Usa 64 Relapsed Refractory 64 Immunomodulatory 64 Upregulation 64 Metastatic Melanoma 64 Reductase 64 IND Application 64 Cell Mol Physiol 64 Am J Obstet 64 Poster Presentation # 64 Red Hat alert RHSA 64 s# s# 64 PT S# 64 Pharmacodynamics 64 Mol Med 64 Liposomal 64 Arthritis Rheum 64 Announcement acc 64 J Antimicrob Chemother 64 Combination REOLYSIN R 64 Cochrane Database Syst Rev 64 Adjuvant Treatment 64 #:#-# [006] 64 CrossRef Medline 64 SUO 64 Modulates 64 Syndr 64 Diabet Med 64 doi #.# 63 Phase IIa Clinical Trial 63 Clinical Trials Update 63 brivanib 63 Cytotoxicity 63 SABCS 63 J Consult Clin 63 TVID 63 #:# -# [005] 63 Ispinesib SB # 63 T# R# 63 #:#-# [002] 63 Radiol 63 Interv 63 J Shoulder Elbow 63 Meta Analysis 63 Metastatic Renal Cell Carcinoma 63 Genome Res 63 sunitinib Sutent ® 63 Pharmacodynamic 63 Randomized Double Blind Placebo 63 Scand J 63 Aurora Kinase 63 J Exp Med 63 Psychiatr 63 J Neurosci 63 See CLINICAL PHARMACOLOGY 63 Advanced Renal Cell 63 lexidronam injection 63 Dose Response 63 ,#,# [002] 63 Hemodialysis Patients 63 pjg 63 2DR 63 #nd EORTC NCI 63 Kahalalide F 63 #I [003] 63 Podium Presentation 63 Antitumor 63 SA FC# 63 HDAC Inhibitor 63 dasatinib Sprycel ® 63 Intravascular 63 Patients Treated With 63 Fungal Infections 63 #:# -# [001] 63 Nucleoside 63 #PD 63 SUN MAY 63 Nat Neurosci 63 Immunogenicity 63 Mol Psychiatry 63 1beta 63 Cannabinoid 63 Prognostic Significance 63 Phase 2a Clinical Trial 63 Reprod 63 Inhibits 63 Arch Facial Plast 63 Phase 2b Trial 63 Schizophr Res 63 Is Well Tolerated 63 J Infect Dis 63 Vaccine Adjuvant 63 Peginterferon 63 Ann Surg 63 Intracranial Aneurysms 63 Cell Mol Biol 63 Unresectable 63 Synthase 63 Adjunctive Therapy 63 essential thrombocythemia ET 63 NIH Publication 63 #:#-# [037] 63 Diffuse Large B 63 Oritavancin 63 Chemoradiation 63 Metab Disord 63 Drug Discov 63 Clin Orthop 63 Pharmacother 63 EGFR HER2 63 Article PubMed ChemPort 63 Psychiatric Services #:#-#,# 63 Epub ahead 63 Solid Tumors 63 Annu Rev 63 S# T# R# 63 syngeneic 63 Placebo Controlled Trial 63 -# Totals [001] 63 Controlled Trial 63 Nat Biotechnol 63 Clinical Efficacy 63 Contrast Agents 63 J Physiol 63 metastatic malignant 63 #:#-# [030] 63 Cancer Incidence Mortality 63 Localized Prostate Cancer 63 Lymphocytic 63 Oral Presentation # 63 regulated kinase 63 Pegylated Liposomal Doxorubicin 63 Percutaneous Tibial Nerve Stimulation 63 Eur Respir J. 63 Am Fam Physician 63 Randomized Double blind 63 ^ sup #m 63 Prospective Randomized Trial 63 selective agonist 63 Biotechnol 63 #N [005] 63 #:#-# [019] 63 Eur J Pharmacol 62 Bosutinib 62 FASEB J 62 #-# Abstract Full [002] 62 J Fam Pract 62 Placebo Controlled Study 62 Tumor Response 62 Gynecol 62 Mol Cell Biol 62 Pharmacokinetics 62 Fibrinogen 62 Myeloid 62 Newly Diagnosed Multiple Myeloma 62 fosbretabulin 62 J Acquir Immune Defic 62 5 Fluorouracil 62 Anticancer Activity 62 J Nucl Med 62 deoxyglucose 62 irreversible inhibitor 62 Beta Amyloid 62 liposomal amphotericin B 62 Randomized Clinical Trials 62 Ultrasensitive 62 HKEY CLASSES ROOT CLSID 62 Monoclonal 62 Br J Haematol 62 Peginterferon Alfa 2a 62 App'x 62 Secretase 62 Psychiatr Serv 62 Aflibercept 62 Lung Tumors 62 TRAIL receptors 62 HLA DR4 62 mediated inhibition 62 이다 62 Attenuates 62 Carcinomas 62 #:#-# [028] 62 Nicotine Vaccine 62 Tumor Angiogenesis 62 Linezolid 62 Demonstrates Potent 62 Article PubMed 62 Presents Preclinical Data 62 ara C 62 #S #S [001] 62 Receptor Antagonists 62 EMRG VIO 62 Hematopoietic Stem Cells 62 Arch Surg 62 Anticancer Drug 62 Renal Cell Carcinoma 62 Oral Abstract 62 AUTO 5SPD 62 Hosp Epidemiol 62 Metastatic Prostate Cancer 62 1α 62 Eur J Neurol 62 Fulvestrant 62 Miner Res 62 AnaSpec Introduces 62 Pl. s 62 Myelodysplastic Syndromes 62 Poster Presentations 62 Dose Finding 62 는 의 62 triciribine phosphate monohydrate 62 downregulates 62 Clinical Trial Data 62 Immunosuppression 62 pT2 62 Initiate Phase 62 Biological Therapy 62 Liver Tumors 62 Surg 62 pan HDAC inhibitor 62 Nilotinib 62 entitled Synergistic 62 • dcastell@visalia.gannett.com • 62 non nucleoside inhibitor 62 ASCO abstract 62 Inj 62 5 hydroxytryptamine 62 DNA intercalator 62 E2 CLO 62 Arch Dis Child 62 Btk Inhibitor PCI 62 Genotypes 62 Joint Surg Am 62 Acta Paediatr 62 Health Aff Millwood 62 Double Blind Placebo 62 Previously Treated 62 Interferon alfa 62 Hypertens 62 :2 62 Interferon Alfa 62 Renal Physiol 62 dimeglumine 62 Protease Inhibitor 62 Mimetics 62 Allogeneic 62 Hematological Malignancies 62 mineralocorticoid receptor 62 Disord 62 Clin Cancer 62 Breast Ultrasound 62 TIMP 62 Ecallantide 62 Humanized Anti 62 Bare Metal Stent 62 ASCO GI 62 Mantle Cell Lymphoma 62 Tumor Suppressor 62 Prostate Cancer Progression 62 Unfractionated Heparin 62 #:#-# [007] 62 AASLD Meeting 62 Phase 2a Trial 62 monocyte chemotactic protein 62 Well Tolerated 62 Assay Kit 62 Conjugate 62 B Cell Lymphoma 62 vitro cytotoxicity 62 somatostatin analog 62 Intracoronary 62 huN# DM1 62 cyclin dependent kinase inhibitor 62 Selective Inhibitor 61 Gastroenterol 61 murine model 61 Engl J Med 61 Pharmacol 61 T8N 61 Int J Obes Relat 61 Stent Thrombosis 61 VINES A. 61 TO AVOID PREGNANCY WHILE 61 Respiratory Virus 61 Arch Otolaryngol Head 61 WALDEN T. AR 61 HBeAg + 61 selective kinase inhibitor 61 Inflammatory Pain 61 Treating Chronic 61 ASCO GU 61 Preclinical Models 61 RU EUROPE ASIA EEU 61 Î ² 61 RNAi Therapeutic 61 EZN 61 Article ChemPort 61 Completes Patient Enrollment 61 Am Soc Nephrol 61 Endometrial 61 surgically resected 61 carboxypeptidase 61 K. pneumoniae 61 hematoxylin eosin original 61 Infected Patients 61 Psychosom Med 61 Improve Survival 61 RENAL 61 Immunomedics Announces 61 Bruton tyrosine kinase 61 AT APPROXIMATELY 61 J Hypertens 61 selective antagonist 61 PEGylated Fab fragment 61 AACR NCI EORTC 61 Neurobiol 61 #:#-# [001] 61 World J Gastroenterol 61 Gastrointest Liver Physiol 61 #/#/à = I 61 Recombinant Human 61 urothelial carcinoma 61 Endothelial 61 Lenalidomide 61 Osteoporos Int 61 IFN α 61 methionine aminopeptidase 61 Receptor Agonist 61 Randomized Study 61 #-# Abstract Full [001] 61 Receives Orphan Drug Designation 61 Janus Kinase 61 Streptococcus agalactiae 61 EMRG POL 61 SensoLyte ® 61 Complicated Skin 61 Critically Ill Patients 61 POL PRO 61 Segregated Facilities Feb 61 Anticoagulant 61 Treatment Experienced 61 e# [005] 61 Cardiovasc 61 selectively binds 61 Reverse Transcriptase 61 Sirolimus Eluting Stent 61 induces apoptosis 61 Oropharyngeal 61 Aust Psychiatry 61 Antiangiogenic 61 Anthrax Toxin 61 adrenoceptor 61 ps :# 61 Cardiotoxicity 61 Prevalence Worldwide 61 AACR Meeting 61 Smooth Muscle 61 Regul Integr Comp Physiol 61 Novel Method 61 Induction Chemotherapy 61 liposome injection 61 FDA Approvals 61 Highly Potent 61 Geriatr 61 RU EEU EUROPE ASIA 61 Novel Small Molecule 61 Tumor Necrosis Factor 61 Bipolar Disord 61 spud #-#-# drlg [003] 61 alfa 2a 61 function var = 61 assessing T DM1 61 LPS induced 61 Biochem Pharmacol 61 ASSAY 61 humanized interleukin 6 61 CYP#A# CYP#D# 61 pDC 61 Phase IIb Clinical Trial 61 Estrogen Receptor 61 Leukemias 61 Nodule 61 Cardiac Troponin 61 hepatoma 61 General Psychiatry #:#-#,# 61 e# [001] 61 Telaprevir VX 61 Phase IIb Trial 61 Advanced Melanoma 61 Synthetic Peptide 61 Selective Cardiac Myosin Activator 61 FOLFOX6 61 Janus kinase 61 Def. s 61 Novel Antibiotic 61 Postprandial 61 CAVER T. AR 61 dual endothelin receptor antagonist 61 Studien 61 Int J Geriatr Psychiatry 61 Dose Escalation Study 61 ITA Kawasaki ZX 61 S#.# [006] 61 vapreotide acetate 61 ERA EDTA 61 Shows Promising 61 Prospective Randomized 61 Mg Uk 61 unfractionated heparin UFH 61 By JENNIFER LEARN 61 Cyclooxygenase 2 61 NSABP B 61 Follicular Lymphoma 61 Cytotoxic T 61 bevacizumab Avastin R 61 Coronary Angiography 61 Ibritumomab Tiuxetan 61 Randomized Controlled Trials 61 Chronic Sinusitis 61 Cyclophosphamide 61 Histopathologic 61 Subtypes 61 interleukin IL 61 annexin V 61 Ann Thorac Surg 61 Hall BF Poster 61 PMID # [001] 61 Patients Receiving 61 Calgary AB T2P 61 Orthop 61 ACC2 61 1alpha 61 LENALIDOMIDE 61 Anesth Analg 61 Isavuconazole 61 Mouse Models 61 Biologic Therapy 61 美 通 社 61 Patients Treated 61 PROSTASCINT R 61 Stent Restenosis 61 solithromycin 61 HER1 61 J Cataract Refract 61 Hypertensive Patients 61 Oral Presentations 61 S1 S# [001] 61 ESMO Accepted Abstract 61 Subtype 61 Low Dose 61 myelodysplastic myeloproliferative diseases 61 Tubulin 61 jason.hovet @ thomson.com +# 61 cetuximab Erbitux R 61 Pivotal Phase III 61 Cell Proliferation 61 Trial Evaluating 60 Malignant Melanoma 60 Investigational Agent 60 NMIBC 60 Bacteremia 60 Subcutaneous 60 prostate carcinoma 60 MT# MEDI 60 대통령 60 J Cardiovasc 60 cis retinoic acid 60 Files IND 60 Non Alcoholic Steatohepatitis 60 :# [002] 60 #:#-# [016] 60 Combination Clinical Trial 60 SYN# 60 AACR IASLC Joint 60 Refractory Hodgkin Lymphoma 60 Clinical Trial Evaluating 60 Improves Outcomes 60 Protease Inhibitors 60 Antiplatelet 60 Female Urology 60 Macrophage 60 TIMP 1 60 Receptor Antagonist 60 AAG geldanamycin analog 60 Randomized Double Blind 60 familial amyloidotic polyneuropathy FAP 60 pawel.sobczak @ thomson.com 60 J Gerontol 60 Clin Endocrinol 60 Controlled Study 60 gemcitabine Gemzar ® 60 Interferon gamma 60 humanized monoclonal 60 J Neurol Neurosurg Psychiatry 60 Transgenic Mice 60 Sevelamer 60 Deadlinepix 60 mso ansi language 60 pan histone deacetylase 60 J Am Podiatr 60 tubulin polymerization 60 Onc 60 Arterial Disease 60 sodium glucose cotransporter 60 thomson.com afp 60 ECCMID 60 Heart Failure Patients 60 Cogn 60 이 을 60 Demonstrates Significant 60 J Periodontol 60 Phosphorylation 60 Pl. 60 Relapsing Remitting Multiple Sclerosis 60 BRASIL :# 60 Ann Neurol 60 Monotherapy 60 generation antisense inhibitor 60 μg ml 60 Advanced Colorectal Cancer 60 Histologic 60 Myocardial Perfusion Imaging 60 MR Angiography 60 Subunit 60 Infect Control 60 Confocal 60 Intracellular 60 #:#-# [024] 60 TRAIL induced apoptosis 60 FAXES USA :1 60 ErbB2 positive 60 § #E 60 Azacitidine 60 Coronary Arteries 60 Lascorz J. 60 Clin Trials 60 Left Ventricular 60 Article PubMed ISI ChemPort 60 Bone Metastases 60 J Immunol 60 Randomized Phase II 60 PLoS Genet 60 Deutsche Presse Agentur GmbH 60 Radiat 60 J Psychosom Res 60 Randomized Clinical Trial 60 Thrombotic 60 Oral Formulation 60 DO NOT EMAIL 60 Breast Cancer Cells 60 Safinamide 60 Patency 60 Recap BAL 60 Pegylated 60 Analogs 60 Hum Mol Genet 60 Inflammatory Arthritis 60 selectively inhibited 60 Pharmacokinetic PK 60 Confirmatory Phase 60 hydroxylase 60 Resp 60 Adenoviral 60 null mice 60 J Thorac Cardiovasc Surg 60 J Cereb Blood 60 Content Outline 60 Expert Opin 60 CCL2 60 transcranial Doppler ultrasound 60 annexin 60 tumor xenograft models 60 Epidemiol 60 Pemetrexed 60 Xenograft 60 Quantitation 60 NTx 60 Diabetic Foot Ulcer 60 Refractory Angina 60 Mycophenolate Mofetil 60 HMQ MT 60 Papillary 60 Cell Lymphoma 60 cisplatin gemcitabine 60 Polymorphisms 60 Hematopoietic 60 Prospective Multicenter 60 Puls Biznesu pp. 60 #:#-# [014] 60 Epidermal Growth Factor Receptor 60 acyltransferase 60 과 60 #a #a [002] 60 Kinase Inhibitors 60 ERalpha 60 Chemother 60 Autoantibodies 60 ChemPort 60 Compr Psychiatry 60 CYT# potent vascular disrupting 60 cisplatin resistant 60 KL WN 60 ^ sup + 60 Tipranavir 60 TH PO# 60 Brain Metastases 60 Adenoma 60 :# [003] 60 Renal Impairment 60 Targeted Therapy 60 FDA APPROVES 60 mouse xenograft models 60 J Abnorm Psychol 60 Plast Reconstr Surg 60 histologic findings 60 Bronchiectasis 60 antitrypsin 60 resistant hormone refractory 60 Catenin 60 #:# -# [003] 60 Slow Progression 60 Phospholipase 60 Granted Orphan Drug 60 THE METROPOLITAN OPERA 60 Nebulized 60 POST CONVICTION RELIEF 60 L# L# [001] 60 CD# CD# 60 phosphate dehydrogenase 60 #:#-# [010] 60 Developmental Therapeutics Immunotherapy 60 mg TID 60 Annual ICAAC 60 DEV DA TOMAR NEXT 60 gag pol 60 Hepatocellular Carcinoma 60 J Hum Genet 60 Treatment Naïve 60 CASE NUMBER 60 Patients Undergoing 60 J Endocrinol 60 Initiates Clinical Trial 60 J Neurosurg 60 Occup 60 5alpha reductase 60 Sapacitabine 60 Appears Safe 60 3AB 60 Echocardiographic 60 colon carcinoma 60 PHASE II 60 bFGF 60 COVIDIEN 60 mimetic peptide 60 Chemokine Receptor 60 Breast Carcinoma 60 Intra arterial 60 Circulating Tumor Cells 60 CLL SLL 60 Marilyn.Wimp @ phil.frb.org 60 Valvular 60 Non Responders 60 Cilostazol 60 orally administered inhibitor 60 Proliferative 60 verteporfin 60 Disease Modifying 60 GOOD MORNING TURKEY PRESS 60 #.#/journal.pmed.# 60 Adult Stem Cell Therapy 60 Overexpression 60 Endothelial Cells 60 한 60 JAK2 Inhibitor 60 Hepatitis C Genotype 60 Vasc 60 Med Sci Sports Exerc 60 #/Aug 60 TAGS PGOV 60 Radiofrequency Ablation 60 Hennekens CH 60 Sirolimus Eluting 60 #a #a [003] 60 Respir Med 60 doi #.#/s#-#-#-# 60 Tramiprosate 60 Paediatr 60 HT 1A 60 # AR [001] 60 TRUS 60 Systemic Delivery 60 Angiotensin Converting Enzyme 60 Immunohistochemical staining 60 Small Molecule Inhibitors 60 Ala. Civ 60 Interferon Gamma 60 Statistically Significant 60 ovarian carcinoma 60 Radiation Induced 60 Clin Nutr 60 Telephone +# [001] 60 Clinical Evaluation 60 relapsed MM 60 ERRED WHEN IT 60 TRAIL R2 60 liposomal formulation 60 selective modulator 60 Phosphatase 60 Protein Synthesis 60 TLR antagonist 60 은 60 agb 60 adrenomedullin 60 Demonstrates Positive 60 :5 60 Nucl Med 60 MDA MB 60 Kidney Transplant Patients 59 Hyperlipidemia 59 J Pathol 59 Adjuvant Therapy 59 Histone 59 M. MELENDEZ 59 PATENT FOR 59 culture supernatants 59 EORTC 59 Private chg : 59 Placebo Controlled 59 Osteoporosis Treatment 59 somatostatin analogue 59 JOSEPH SAPIA • 59 Helixate R 59 Non Invasive Treatment 59 Proves Effective 59 Bosentan